UNION KOREA PHARM CO.,Ltd
Established 1985, KOSDAQ-listed 2018, it makes antibiotic, cardiovascular, and GI prescription drugs and offers CMO services.
As of 2026-10-10, UNION KOREA PHARM CO.,Ltd has 345 Korean MFDS drug approvals on record (counted by the MAA Company Index from its own matching of public databases).
Price
Change
Market cap
Business overview
Source: DART corporate disclosureFounded in 1985 and listed on KOSDAQ in 2018, it is a prescription drug manufacturer and contract manufacturer (CMO). It produces antibiotic, musculoskeletal, cardiovascular, and gastrointestinal finished drugs using solid-dosage (tablets, capsules), liquid injection, and cephalosporin powder injection formulations, while expanding into respiratory and urological products. It exports finished drugs to the Middle East, Southeast Asia, and Latin America, winning a USD 5 million Export Tower award in 2009, and is expanding into India, China, Yemen, Iraq, and Peru while also operating a CMO business for other pharmaceutical companies.
Products & technology
- 라모제아주antiemetic
- 에피나코나졸 외용액
- 크로피겔정
- 도네페질정
Regulatory approvals
data.go.kr345 Korean MFDS drug approvals · 1988–2025
- MFDS drugNewranso-X-tab.2025-03-14Drug · Prescription · Approval202500566
- MFDS drugGinkgonek Tab. 240mg2024-10-29Drug · OTC · Notification202402554
- MFDS drugNewbla Topical Solution2024-07-08Drug · Prescription · Approval202401664
- MFDS drugPlotex Tab.2024-04-11Drug · Prescription · Approval202400823
- MFDS drugRamozea inj.2024-02-29Drug · Prescription · Approval202400443
- MFDS drugKefodon Inj. 0.5g2024-01-22Drug · Prescription · Approval202400158
- MFDS drugUniila plus tab.2023-08-10Drug · Prescription · Approval202302395
- MFDS drugUniedoxaban Tab. 30mg2023-06-29Drug · Prescription · Approval202301995
- MFDS drugUniedoxaban Tab. 60mg2023-06-29Drug · Prescription · Approval202301996
- MFDS drugKefodon Inj. 2g2023-05-16Drug · Prescription · Notification202301568
- MFDS drugUnibrex Cap. 100mg2023-03-22Drug · Prescription · Approval202301004
- MFDS drugUplama Inj.2023-02-15Drug · Prescription · Notification202300558
Show 68 more
- MFDS drugNewRanso-X tab.2023-01-09Drug · Prescription · Approval202300171
- MFDS drugDapaseeglo Tab.10/100mg2023-01-09Drug · Prescription · Approval202300176
- MFDS drugDuallow tab. 30/2.5mg2023-01-06Drug · Prescription · Approval202300123
- MFDS drugDuallow tab. 30/2.5mg2023-01-06Drug · Prescription · Approval202300132
- MFDS drugUnibepota SR Tab.2022-12-21Drug · Prescription · Approval202204554
- MFDS drugUniperamivir Inj.2022-07-25Drug · Prescription · Approval202203062
- MFDS drugCogaparkNasal Spray2022-07-01Drug · OTC · Notification202202743
- MFDS drugTopla 5mg Tab.2022-05-12Drug · Prescription · Approval202201982
- MFDS drugUnimadex Inj.2022-04-08Drug · Prescription · Approval202201489
- MFDS drugSitauniduo 50/850mg2022-01-25Drug · Prescription · Approval202200408
- MFDS drugSitauniduo tab. 50/500mg2022-01-25Drug · Prescription · Approval202200409
- MFDS drugSitauniduo tab.2022-01-25Drug · Prescription · Approval202200410
- MFDS drugUnifenidon Tab. 200mg2022-01-20Drug · Prescription · Approval202200358
- MFDS drugUnifenidone Tab. 400mg2022-01-20Drug · Prescription · Approval202200359
- MFDS drugGropesia Tab. 10mg2021-08-25Drug · Prescription · Approval202106154
- MFDS drugUnion Zoledronic Acid Inj. 5mg/100mL2021-06-03Drug · Prescription · Approval202104345
- MFDS drugCerofem Inj. 2g(for export)2021-04-30Drug · Prescription · Approval202103543
- MFDS drugRivasavan Tab. 20 mg2021-04-28Drug · Prescription · Approval202103483
- MFDS drugUcoxia tab. 30mg2021-04-27Drug · Prescription · Approval202103413
- MFDS drugUnion Donepezil Tab. 23mgRevoked2021-04-07Drug · Prescription · Approval202102969
- MFDS drugRivasavan tab.2021-03-30Drug · Prescription · Approval202102754
- MFDS drugRivasavan Tab. 15mg2021-03-30Drug · Prescription · Approval202102755
- MFDS drugUnimin Inj. 8.5%Revoked2021-03-08Drug · Prescription · Notification202102150
- MFDS drugMinoxidil Tab. UnionkorRevoked2021-03-04Drug · Prescription · Notification202102018
- MFDS drugOLPITOZET tablet 10/10mg2021-02-19Drug · Prescription · Approval202101674
- MFDS drugOLPITOZET tablet 10/20mg2021-02-19Drug · Prescription · Approval202101675
- MFDS drugOLPITOZET tablet 10/40mg2021-02-19Drug · Prescription · Approval202101676
- MFDS drugTorzeto Tab. 10/10mgRevoked2021-02-18Drug · Prescription · Approval202101524
- MFDS drugTorzeto Tab. 10/20mgRevoked2021-02-18Drug · Prescription · Approval202101525
- MFDS drugTorzeto Tab. 10/40mgRevoked2021-02-18Drug · Prescription · Approval202101526
- MFDS drugSitauni tabl. 25mg2021-01-06Drug · Prescription · Approval202100085
- MFDS drugSitauni tab. 50mg2021-01-06Drug · Prescription · Approval202100086
- MFDS drugSitauni tab. 100mg2021-01-06Drug · Prescription · Approval202100087
- MFDS drugalphamosin Inj.2020-10-28Drug · Prescription · Approval202007386
- MFDS drugCereni Inj.2020-10-16Drug · Prescription · Notification202007121
- MFDS drugYudat Tab. 0.5mg2020-08-03Drug · Prescription · Approval202005608
- MFDS drugDapaglo Tab. 10mgRevoked2020-06-17Drug · Prescription · Approval202004458
- MFDS drugHyroneye Eye Drop 0.3%Revoked2020-06-11Drug · Prescription · Notification202004329
- MFDS drugHyroneye Eye Drop 0.15%Revoked2020-06-10Drug · Prescription · Notification202004324
- MFDS drugGinkgonek Tab. 80mg2020-05-29Drug · OTC · Notification202004081
- MFDS drugUnion Acetaminophenbag Inj.2020-05-14Drug · Prescription · Notification202003487
- MFDS drugUnitop Tab. 5mgRevoked2020-05-07Drug · Prescription · Approval202003323
- MFDS drugUnimega Mini soft cap.2020-05-04Drug · Prescription · Approval202003264
- MFDS drugAtracen semi Tab.2020-04-29Drug · Prescription · Approval202003201
- MFDS drugUniren 2X Tab.Revoked2020-04-27Drug · Prescription · Approval202003080
- MFDS drugUnion Multi Inj.Revoked2020-04-08Drug · Prescription · Notification202002483
- MFDS drugGinkgonek Tab. 4mg2020-04-03Drug · OTC · Notification202002342
- MFDS drugUnion Tulobuterol Patch 0.5mg2020-03-19Drug · Prescription · Approval202001970
- MFDS drugUnion Tulobuterol Patch 1mg2020-03-19Drug · Prescription · Approval202001971
- MFDS drugUnion Tulobuterol Patch 2mg2020-03-19Drug · Prescription · Approval202001972
- MFDS drugTelrow Tab. 40/10mg2020-03-17Drug · Prescription · Approval202001848
- MFDS drugTelrow Tab. 40/5mg2020-03-17Drug · Prescription · Approval202001850
- MFDS drugTelrow Tab. 80/10mg2020-03-17Drug · Prescription · Approval202001851
- MFDS drugTelrow Tab. 80/5mg2020-03-17Drug · Prescription · Approval202001853
- MFDS drugTelrow Tab. 40/20mgRevoked2020-03-17Drug · Prescription · Approval202001849
- MFDS drugTelrow Tab. 80/20mgRevoked2020-03-17Drug · Prescription · Approval202001852
- MFDS drugUnirori Cap. 1mg2020-02-28Drug · Prescription · Approval202001412
- MFDS drugUnirori Cap. 0.5mg2020-02-28Drug · Prescription · Approval202001413
- MFDS drugUniron Inj.2020-02-11Drug · Prescription · Approval202000799
- MFDS drugUnion Selenium Inj.2020-02-07Drug · Prescription · Notification202000741
- MFDS drugCefuny Dry SyrupRevoked2020-01-20Drug · Prescription · Approval202000278
- MFDS drugUnion Rasagiline Tab. 0.5mg2020-01-15Drug · Prescription · Approval202000219
- MFDS drugUnion Rasagiline Tab. 1mg2020-01-15Drug · Prescription · Approval202000220
- MFDS drugCefouni Tab.Revoked2020-01-15Drug · Prescription · Approval202000230
- MFDS drugNewlotan Tab. 100mg2020-01-08Drug · Prescription · Approval202000113
- MFDS drugMuster Tab. 20mgRevoked2020-01-08Drug · Prescription · Approval202000114
- MFDS drugEsone SR Tab.Revoked2019-12-24Drug · Prescription · Approval201908626
- MFDS drugUnimin Inj. 5%2019-12-23Drug · Prescription · Notification201908583
Showing the 80 most recent of 345 records.
Clinical trials
data.go.kr18 MFDS clinical trial authorisations · 2013–2024 (Bioequivalence 17 · Phase 3 1)
- Bioequivalence유니미녹시딜정2024-02-21
2 trial sites
- Bioequivalence유니미녹시딜정2023-05-15
2 trial sites
- Bioequivalence레프로핀정(레보드로프로피진)2023-02-14
2 trial sites
- Bioequivalence유니브렉스캡슐(세레콕시브)2021-11-17
2 trial sites
- Bioequivalence크로피겔정(클로피도그렐황산염)2021-07-27
1 trial site
- Bioequivalence뉴란소캡슐30밀리그램(란소프라졸과립)2021-07-26
1 trial site
- Bioequivalence아토르반정20mg(아토르바스타틴칼슘삼수화물)2021-03-05
1 trial site
- Bioequivalence뉴로탄플러스에프정2020-12-30
1 trial site
- Bioequivalence모사티딘정(모사프리드시트르산염수화물)2020-09-21
1 trial site
- Bioequivalence이토리드정(이토프리드염산염)2020-05-13
1 trial site
- Bioequivalence뉴로탄정100밀리그램(로사르탄칼륨)2018-08-03
2 trial sites
- Bioequivalence유니네콜정(베타네콜염화물)2017-02-07
2 trial sites
Show 6 more
- Bioequivalence마이토닌정25밀리그램(베타네콜염화물)2016-11-25
2 trial sites
- Bioequivalence유니온보리코나졸정(가칭)2015-11-27
2 trial sites
- Bioequivalence유니알포정(콜린알포세레이트)2015-11-19
2 trial sites
- Bioequivalence조바코정(심바스타틴)2014-03-14
2 trial sites
- Phase 3뉴클러 F정(UKP-707)2013-08-19
5 trial sites
- Bioequivalence유니온리팍시민정(리팍시민)2013-05-02
R&D and key agreements
Source: DART corporate disclosure아텔로콜라겐 기반 압타머-약물 결합체 · 췌장암 · Developing a targeted drug delivery system with over 1 month of sustained drug release
압타머 기반 생체분자 영상화 기술 · Her2 양성 유방암 · Developing a customized diagnostic contrast agent
돈피 유래 생체적합 젤라틴 혈장증량제 · Producing biocompatible gelatin from pig skin for a plasma expander injection
항응고제 지속방출 제제 · Developing an improved new drug with sustained release to improve dosing convenience and adherence
Key disclosures
KRX KIND via OpenDARTShow 40 more events
Patents
KIPRIS · applicant-matchedRegistered · 2023-11 · Application 1020230156220
Rejected · 2020-12 · Application 1020200181008
Registered · 2019-12 · Application 1020190160525
Rejected · 2019-10 · Application 1020190125949
Rejected · 2019-10 · Application 1020190125942
Rejected · 2019-10 · Application 1020190125926
Rejected · 2019-09 · Application 1020190113988
Rejected · 2019-09 · Application 1020190113967
Rejected · 2019-09 · Application 1020190113976
Registered · 2019-06 · Application 1020190067191
Show 7 more patents
Registered · 2016-07 · Application 1020160092175
Registered · 2015-03 · Application 1020150031153
CN · Published · 2012-11 · Application 201280044865
PCT · Published · 2012-11 · Application PCT/KR2012/009391
Expired · 2012-06 · Application 1020120064563
PCT · Published · 2009-11 · Application PCT/KR2009/006620
Withdrawn · 2008-11 · Application 1020080111568
AI reads
MAA server logs · IP-verifiedPulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.
Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.
Collected as raw material for future answers.
Queries from users who connected this index to their own AI.
- OpenAIChatGPT-Userlive1
- OpenAIOAI-SearchBot62
- PerplexityPerplexityBot3
- AnthropicClaudeBot2
- MicrosoftBingbot1
- GoogleGoogleOther1
Measured since Aug 27, 2026 · 5 AI engines · last read Oct 9, 2026
User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.
Connect this company index directly to your AI
Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for UNION KOREA PHARM CO.,Ltd and every listed Korean medical, bio and AI company.
How to connect (MCP)Companies in the same categoryPharma & CDMO
Founded in 1941 and listed on the KOSPI in 1975, Ildong Holdings is the holding company of the Ildong Pharmaceutical Group, overseeing pharmaceutical, aesthetic medical device, and drug development affiliates.
Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.
Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.
Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.
KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.
KOSPI-listed pharmaceutical company behind Coldwon cold medicine and Jangdaewon probiotics, developing a P-CAB drug pipeline.
Founded 2011, listed 2016 — Samsung Biologics is a biopharma CDMO with 785,000L capacity across five Songdo plants.
Founded in 2006 and listed on KOSDAQ in 2020, Genolution is a molecular diagnostics and RNAi company producing nucleic acid extraction reagents and devices.
Ahn-Gook Pharmaceutical sells the cough/expectorant drug Sinecuran and the eye-health supplement Tobicom.
Founded in 2003 and listed on KOSDAQ in 2015, Corestem Chemon develops stem cell therapies and provides nonclinical CRO services, including the ALS treatment Neuronata-R.
Founded 2005, KOSDAQ-listed 2022, BIO-FD&C develops plant-cell platform-based cosmeceutical materials and biopharma pipelines.
KOSPI-listed comprehensive pharma company behind Amaryl diabetes drug and the USD 86.25M HL5101 anticancer out-license deal.
Sources and updates
Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- Approvals & clinical trials
- Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
- Key disclosures
- KRX KIND via OpenDART exchange filings — updated daily
- Global clinical trials
- ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
- Financials
- DART corporate disclosure filings — annual
- Publications
- PubMed (US National Library of Medicine) — affiliation-matched, updated daily
- Patents
- KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
- AI reads
- Our server logs, IP-verified every 6 hours
- AI visibility
- Measured 2026-10-01
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition